ClinicalTrials.Veeva

Menu

Platelet-rich Fibrin Versus HIFU in Management of Stress Urinary Incontinence

I

Intima Clinic

Status

Unknown

Conditions

Stress Urinary Incontinence

Treatments

Procedure: HIFU
Procedure: Fibrin

Study type

Interventional

Funder types

Industry

Identifiers

NCT04144829
Intima1/2019

Details and patient eligibility

About

Aim of the study is to compare effect of High Intensity Focused Ultrasound (HIFU) and platelet-rich fibrin in management of stress urinary incontinence.

It is a randomized prospective study. After assigning to one of the two groups, patients will undergo relevant treatment.

First group will undergo 3 cycles of intravaginal HIFU treatment in 6-weeks interval.

Second group will undergo 3 injections of platelet-rich fibrin under urethra. Before the treatment and after 2, 6 and 12 months after treatment is finished patients will be asked to fill questionaries concerning quality of life ICIQ-UI SF, ICIQ-LUTS, PISQ12, FSFI.

Before each treatment cycle patients will be examined and asked to fill daily micturition plan.

Enrollment

200 estimated patients

Sex

Female

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • stress urinary incontinence of low grade
  • separate episodes of urinary incontinence (associated with increase of abdominal pressure)
  • no cystocoele or cystocoele POPQ1
  • positive cough test when filled bladder

Exclusion criteria

  • POPQ 2 and more
  • patients after urogenital operations or radiation
  • neuromuscular, hematologic, autoimmune, uncontrolled psychiatric diseases
  • uncontrolled diabetes
  • pregnancy, lactation
  • patients undergoing conservative treatment for stress urinary incontinence
  • ASA or other anti-platelet drug intake less than 7 days before and 7 days after procedure
  • active carcinomas or status less than 5 years after treatment
  • sepsis
  • infection in treated region

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

HIFU
Active Comparator group
Description:
3 cycles of HIFU treatment in 6-week intervals
Treatment:
Procedure: HIFU
Fibrin
Active Comparator group
Description:
3 cycles of platelet-rich fibrin injection treatment in 6-week intervals
Treatment:
Procedure: Fibrin

Trial contacts and locations

1

Loading...

Central trial contact

Tomasz Basta, PhD; Anna Horbaczewska, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems